ArticlemedRxiv : the preprint server for health sciences2025
Differential microRNA expression profiling of peripheral blood L1CAM neural-enriched and bulk extracellular vesicles in individuals with bipolar disorder.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
Abstract
Bipolar disorder (BD) is a common and yet poorly elucidated psychiatric disorder, with emerging evidence implicating a role for epigenetic mechanisms, including microRNAs (miRNAs), in its pathophysiology. These molecules are secreted from cells in extracellular vesicles (EVs), which can be isolated from bodily fluids and tested as potential biomarkers. In individuals with BD and control participants (CON), we characterized the miRNA expression profiles of peripheral blood EVs selected for L1CAM, a putative neuronal marker, as well as bulk peripheral blood EVs. Peripheral blood EVs were isolated from n=20 BD and 20 CON (L1CAM) and n=21 BD and 20 CON (bulk). Within each study, analyses identified miRNAs that were differentially expressed between BD and CON, followed by functional interrogation and testing for associations with clinical features. Results were then compared to better understand the relative specificity of bulk and L1CAM EV analyses. Thirty-four miRNAs were differentially expressed between groups in L1CAM EVs, whereas 10 differentially expressed miRNAs were identified in bulk EVs. Across both analyses, biological pathways attributed to the differentially expressed miRNAs included insulin receptor pathway and type II diabetes mellitus. Importantly, associations of differentially expressed miRNAs with clinical features were only significant in L1CAM EVs. Our results reiterate a crucial role for miRNAs in the pathophysiology of BD and suggest that miRNA signatures of putative neuronal origin more closely correspond to clinical features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.